Skip to main content

Member Log In

Please do not use a Yahoo email for your account. If you are using one, change it now.


Forgot your password?
Time To Act logo and graphic

16 June 2021

The Time To Act campaign, which aims to tackle the stalling of cancer treatment during the pandemic, was launched in May. Professor Antonino Spinelli, ESCP General Secretary, took part in the campaign event and is interviewed here by Nagendra Dudi-Venkata and Yongbo An from ESCP's SoMe Subcommittee.
Cristián Gallardo and Soo Young Lee

14 June 2021

Cristián Gallardo interviews Soo Young Lee from Chonnam National University Hwasun Hospital in Korea in the run-up to ESCP's next Global Reach webinar 'Myths and Evidence in Diverticular Disease'.

10 June 2021

June’s paper of the month looks at the PRODIGE-23 trial, a randomised phase 3 clinical trial which sought to determine whether total neoadjuvant chemotherapy (TNT) before surgery improved disease-free survival (DFS) compared with standard preoperative chemoradiotherapy (CRT) in patients with locally advanced rectal cancer.
Shahnawaz Rasheed and Vittoria Bellato

7 June 2021

Vittoria Bellato interviews Mr Shahnawaz Rasheed, Consultant Surgeon at The Royal Marsden, London, about his experience of  robotic-assisted pelvic exenteration.
Johannes Schultz and Vittoria Bellato

3 June 2021

Vittoria Bellato interviews Johannes Schultz about ESCP’s Guidelines for the Management of Diverticular Disease ahead of ESCP's next Global Reach webinar 'Myths and Evidence in Diverticular Disease'.